Antonia Borovina, Managing Director, Investment Banking, joined Bloom Burton in 2014. At Bloom Burton, Antonia leads the firm’s advisory team, providing clients with advice on scientific, clinical and capital markets strategy. Her team is also responsible for the firm’s technical and commercial due diligence activities.
Antonia has been with Bloom Burton since 2014 and has held several positions in the firm, most recently as Equity Research Analyst, where she researched publicly traded healthcare companies and made investment recommendations. Prior to joining Bloom Burton, Antonia gained business development experience while working for a direct-to-consumer genetic testing startup.
Antonia currently serves on the Emerging Companies Advisory Board of BIOTECanada, the national biotechnology industry association.
Antonia holds a PhD from the Department of Molecular Genetics at the University of Toronto. Her PhD research involved the study of the genetics and cell biology regulating early embryonic development. Antonia also holds a BMSc degree in Biochemistry from Western University.
Antonia Borovina, Managing Director, Investment Banking, joined Bloom Burton in 2014. At Bloom Burton, Antonia leads the firm’s advisory team, providing clients with advice on scientific, clinical and capital markets strategy. Her team is also responsible for the firm’s technical and commercial due diligence activities.
